Literature DB >> 35304602

Biallelic PAN2 variants in individuals with a syndromic neurodevelopmental disorder and multiple congenital anomalies.

Miriam S Reuter1,2,3, Michael Zech4,5, Maja Hempel6, Janine Altmüller7, Tracy Heung8, Laura Pölsler9, René Santer10, Holger Thiele7, Brett Trost11,12, Christian Kubisch6, Stephen W Scherer11,12,13,14, Sabine Rudnik-Schöneborn9, Anne S Bassett8,15,16,17, Davor Lessel6.   

Abstract

PAN2 encodes a subunit of a deadenylation complex with important functions in mRNA stability and post-transcriptional regulation of gene expression. A homozygous frameshift deletion in PAN2 was reported in a single affected individual with developmental delay and multiple congenital anomalies. Here, we describe five additional individuals from three unrelated families with homozygous predicted loss-of-function variants in PAN2. The affected individuals presented with significant overlap in their clinical features, including mild-moderate intellectual disability, hypotonia, sensorineural hearing loss, EEG abnormalities, congenital heart defects (tetralogy of Fallot, septal defects, dilated aortic root), urinary tract malformations, ophthalmological anomalies, short stature with other skeletal anomalies, and craniofacial features including flat occiput, ptosis, long philtrum, and short neck. Our data confirm that biallelic predicted loss-of-function variants in PAN2 cause a syndrome with multiple congenital anomalies, and suggest an important role of mRNA polyA tail length for proper organ formation.
© 2022. The Author(s), under exclusive licence to European Society of Human Genetics.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35304602      PMCID: PMC9090724          DOI: 10.1038/s41431-022-01077-y

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   5.351


  1 in total

1.  No gene to predict the future?

Authors:  Alisdair McNeill
Journal:  Eur J Hum Genet       Date:  2022-05       Impact factor: 5.351

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.